Smith Hunter C
SEC CIK 1636385 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | CFO | 176.8K | — | $19.42M | 47 | 2022-02-11 | 2026-08-31 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 47
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-01 16:22 | 2026-08-31 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $25.79 | +57.2K | 176.8K | +48% | +$1.47M |
| DMT | 2026-09-01 16:22 | 2026-08-31 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $105.46 | -62.8K | 114.0K | -36% | -$6.62M |
| D | 2026-05-20 16:15 | 2026-05-18 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $17.87 | +3,000 | 119.6K | +3% | +$53.6K |
| D | 2026-03-02 | 2026-03-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.80 | +6,099 | 116.6K | +6% | +$41.5K |
| M | 2026-02-19 | 2026-02-17+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $101.31 | -7,954 | 114.9K | -6% | -$805.8K |
| DM | 2026-02-12 | 2026-02-10+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $100.21 | -7,071 | 123.6K | -5% | -$708.6K |
| M | 2026-02-06 | 2026-02-04+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $106.02 | -6,628 | 129.7K | -5% | -$702.7K |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | F - Tax | $108.99 | -10.8K | 132.2K | -8% | -$1.17M |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +26.0K | 142.9K | +22% | — |
| DM | 2025-08-14 | 2025-08-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $96.29 | -28.1K | 116.9K | -19% | -$2.70M |
| DM | 2025-08-14 | 2025-08-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +28.1K | 141.5K | +25% | +$193.2K |
| DM | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $80.48 | -42.1K | 140.3K | -23% | -$3.39M |
| D | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +42.1K | 159.0K | +36% | +$289.8K |
| D | 2025-07-08 | 2025-07-07 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +6,986 | 116.9K | +6% | +$48.1K |
| DM | 2025-06-03 | 2025-05-30 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $61.41 | -23.4K | 128.9K | -15% | -$1.44M |
| D | 2025-06-03 | 2025-05-30 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +23.4K | 133.3K | +21% | +$161.0K |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +6,600 | 112.1K | +6% | — |
| D | 2025-02-19 | 2025-02-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $57.22 | -2,215 | 109.9K | -2% | -$126.7K |
| M | 2025-02-14 | 2025-02-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $56.39 | -751 | 105.5K | -0.7% | -$42.3K |
| DM | 2025-02-11 | 2025-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $57.51 | -1,296 | 106.3K | -1% | -$74.5K |
| DM | 2025-02-11 | 2025-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +6,405 | 105.2K | +6% | — |
| D | 2025-02-04 | 2025-02-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $59.43 | -1,678 | 101.2K | -2% | -$99.7K |
| D | 2025-02-04 | 2025-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +4,925 | 102.9K | +5% | — |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $39.22 | -15.5K | 97.9K | -14% | -$608.5K | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | A - Grant | $0.00 | +33.8K | 113.5K | +42% | $0 |
| DM | 2024-02-13 | 2024-02-12+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $50.80 | -1,918 | 79.7K | -2% | -$97.4K |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +6,407 | 79.3K | +9% | — |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $45.06 | -1,616 | 75.2K | -2% | -$72.8K |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +4,925 | 76.8K | +7% | — |
| D | 2024-01-03 | 2023-12-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +10.5K | 71.9K | +17% | +$72.2K |
| DM | 2023-12-07 | 2023-12-05+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $38.72 | -27.0K | 61.4K | -31% | -$1.05M |
| DM | 2023-12-07 | 2023-12-05+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +27.0K | 68.4K | +65% | +$185.9K |
| D | 2023-11-28 | 2023-11-24 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $35.02 | -11.0K | 61.4K | -15% | -$384.3K |
| D | 2023-11-28 | 2023-11-24 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +11.0K | 72.4K | +18% | +$75.5K |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +12.0K | 73.4K | +20% | +$82.6K |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $30.38 | -12.0K | 61.4K | -16% | -$364.6K |
| D | 2023-06-21 | 2023-06-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | $6.88 | +2,000 | 61.4K | +3% | +$13.8K |
| D | 2023-02-14 | 2023-02-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $26.87 | -702 | 59.4K | -1% | -$18.9K |
| D | 2023-02-14 | 2023-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +2,344 | 60.1K | +4% | — |
| A | 2023-02-14 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale | $27.51 | -1,413 | 57.8K | -2% | -$38.9K |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +4,063 | 59.2K | +7% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $27.66 | -1,398 | 57.8K | -2% | -$38.7K |
| 2022-12-29 | 2022-12-23 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | G - Gift | $0.00 | -2,500 | 55.1K | -4% | $0 | |
| D | 2022-07-06 | 2022-06-30 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +25.0K | 65.2K | +62% | — |
| D | 2022-07-06 | 2022-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $4.08 | -7,547 | 57.6K | -12% | -$30.8K |
| D | 2022-02-15 | 2022-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | M - OptEx | — | +2,344 | 41.0K | +6% | — |
| D | 2022-02-15 | 2022-02-15 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | CFO | S - Sale+OE | $6.10 | -833 | 40.2K | -2% | -$5,081 |
Purchase Sale Sale after option exercise All abbreviations